SCHEMBL14263113

SCHEMBL14263113

CN1CCC(NC(=O)NCc2cccc(C(C)(F)F)c2)CC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 1/20 0.50
MCHR1 Q99705 2/20 0.49
KCNH2 Q12809 1/20 0.49
EPHX1 P07099 1/20 0.46
HPGD P15428 1/20 0.46
UBE2M P61081 4/20 0.46
DCUN1D1 Q96GG9 4/20 0.46
SIGMAR1 Q99720 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
HRH4 Q9H3N8 1/20 0.46
TEAD1 P28347 2/20 0.44
SSTR4 P31391 2/20 0.44
EPHX2 P34913 2/20 0.44
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
SSTR1 P30872 1/20 0.44
CARM1 Q86X55 1/20 0.44
PRMT6 Q96LA8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4980678 0.92 UBE2M (0.54) DRD4MCHR1KCNH2UBE2MDCUN1D1
SCHEMBL14263134 0.85 DRD4 (0.55) DRD4MCHR1EPHX1HPGDMEN1
SCHEMBL14263087 0.85 MCHR1 (0.52) DRD4MCHR1KCNH2EPHX1HPGD
SCHEMBL4981612 0.84 DRD4 (0.57) DRD4MCHR1EPHX1HPGDUBE2M
SCHEMBL4981951 0.84 MCHR1 (0.56) DRD4MCHR1KCNH2EPHX1HPGD
SCHEMBL4982704 0.83 CARM1 (0.55) DRD4MCHR1EPHX1SSTR4EPHX2
SCHEMBL14263126 0.82 SSTR1 (0.57) DRD4MCHR1EPHX1HPGDUBE2M
SCHEMBL14263114 0.81 DRD4 (0.73) DRD4MCHR1EPHX1HPGDMEN1
SCHEMBL4979582 0.80 SLC6A5 (0.59) DRD4MCHR1KCNH2EPHX1HPGD
SCHEMBL4977767 0.80 MCHR1 (0.65) DRD4MCHR1SIGMAR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064706-A1 Piperidine Derivatives as Histamine H3 Receptor Ligands ASTRAZENECA AB (SE) 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064706-A1 Piperidine Derivatives as Histamine H3 Receptor Ligands HRH3, HRH1, HRH4 DRD4 102/4885MCHR1 132/4885KCNH2 434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.